Palate Therapeutics
Palate Therapeutics (IndieBio NY06) is working to address the growing prevalence of metabolic diseases including insulin resistance, obesity, and diabetes. We are developing an oral oligonucleotide therapy to temporarily alter how sweet foods taste and how they metabolized to help change patient's food preferences.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Palate Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- DF
David Francis
CEO, Cofounder · General Business & Management
EmailPhone - MY
Mighten Yip
Chief Scientific Officer · Research & Development
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Palate Therapeutics
2 distinct titles indexed · top 2 shown.
- 2ceo, cofounder
- 1chief scientific officer
Sign up to unlock all 3 contacts at Palate Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Palate Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.